Jan 18, 2021 | Press Release
Wilmington, NC, 18 January 2021 – Evolved from over 15 years serving the biopharma industry, Catalyst Clinical Research formally launched two customized clinical service solutions in January — Catalyst Oncology and Catalyst Flex — to strengthen and expand the CRO’s...
Dec 3, 2020 | Press Release
Raleigh, NC, 4 December 2020 – Catalyst Clinical Research has ranked number nine on the Triangle Business Journal’s (TBJ) list of fastest 50 growing companies for 2020, a designation that salutes the fastest-growing privately held companies in the Research Triangle...
Nov 18, 2020 | Press Release
Wilmington, NC, 18 November 2020 – Catalyst Clinical Research announced today the company has completed the acquisition of Acumen Healthcare Solutions (AHS), a data management software and services company headquartered in Plymouth, Minnesota. Catalyst CEO Nick Dyer...
Aug 12, 2020 | Press Release
Wilmington, NC, 12 August 2020 – For the first time, Wilmington-headquartered Catalyst Clinical Research appears on the Inc. 5000 list of fastest-growing private companies in America. Catalyst ranked 1235 on the list. Recognition on the Inc. 5000 list echoes...
Aug 5, 2020 | Press Release
Wilmington, NC, 4 August 2020 – Catalyst Clinical Research announced today that it has merged with Ce3, Inc. to expand its depth of oncology-specific therapeutic expertise. The combined company is strongly positioned to deliver oncology clinical development services...
Jun 11, 2020 | Press Release
Wilmington, NC, 12 June 2020 – Catalyst Clinical Research, a Wilmington-based award-winning clinical development and global resourcing organization, announced the hiring of Andrew Zupnick, PhD as Vice President of Oncology Drug Development. Dr. Zupnick will be...
